51 - 75 of 1,153
Number of results to display per page
TitleCreatorRelation Is Part Of
51 Retina Nerve Fiber Layer Segmentation with OCT in Patients with Neurodegenerative DiseasesMarcia Marques, Elena Martin, Luis JulvezNANOS 2018: Poster Presentations
52 Simultaneous Neuro-Ophthalmic Presentation and Progression of Idiopathic Intracranial Hypertension and Multiple SclerosisJoao Lemos; Sara Matos; Andre Sobral-Pinho; Andre Jorge; Daniela Pereira; Pedro Fonseca; Ana Martins; Sonia BatistaNANOS Annual Meeting 2023: Poster Session I: Idiopathic Intracranial Hypertension (IIH)
53 Low-Contrast Letter Acuity Loss Over Time in Multiple Sclerosis Correlates with Reductions in Retinal Nerve Fiber Layer Thickness and Macular Volume by OCTBurkholder, Bryn; Winslow, Heather; Nano-Schiavi, M. L.; Pulicken, Mathew; Calabresi, Peter; Galetta, Steven L; Frohman, Elliot; Balcer, Laura JNANOS 2007: Scientific Platform Presentations (Session II)
54 Pattern Electroretinogram for Detecting Retinal Neural Loss in Neuromyelitis Optica and Multiple Sclerosis Patients With or Without Optic Neuritis. Correlation With OCT and Automated PerimetryMonteiro, Mario LR; Hokazono, Kenzo; Raza, Ali S; Oyamada, Maria K; Hood, Donald CNANOS 2013: Poster Presentations
55 Tear Abnormalities in Multiple SclerosisSibony, Patrick A; Coyle, Patricia KMRI vs. All Other Modalities in the Diagnosis of Multiple Sclerosis Symposium
56 Optical Coherence Tomography (OCT) Measurements and Visual Function Tests in a Secondary Progressive MS Trial of the Compound DirucotideTalman, Lauren; Markowitz, Clyde; Cello, Kim; Calabresi, Peter; Galetta, Steven; Werner, Jack; Keltner, John; Balcer, LauraNANOS 2010: Poster Presentations
57 Optical Coherence Tomography (OCT) and Multiple Sclerosis (MS) (video)Steven Galetta, MDNANOS Annual Meeting 2017: Hot Topics in OCT
58 Critical Flicker Fusion as a Novel Measure of Remyelination in Multiple SclerosisKathleen Shangraw, Kimberly Winges, Rebecca Spain, Elizabeth SilbermannNANOS Annual Meeting 2020: Poster Session II: Scientific Advancements
59 Page 16
60 Central Serous Retinopathy Along With Optic Neuritis as the Initial Presentation of Multiple SclerosisNafiseh Hashemi, Maryam NaserNANOS Annual Meeting 2021: Poster Session I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases
61 Immunosuppressive Therapy of Chinese Isolated Non-MS Idiopathic Optic NeuritisXiaojun Zhang, Yunqing Wu, Hanqiu Jiang, Hengri Cong, Lijuan Liu, Jingting Peng, Xiuyun Kong, Rong Yan, Wenbin WeiNANOS 2015: Poster Presentations
62 Pattern Electroretinogram in Patients with Multiple Sclerosis: 2-Year Follow-UpHong Jiang, Qi Chen, Diego Alba, Jeffrey Hernandez, Silvia Delgado, Vittorio Porciatti, Jianhua WangNANOS Annual Meeting 2020: Poster Session II: Scientific Advancements
63 Pediatric Research Collaboration ExPloring Tests In Ocular Neuroimmunology (PERCEPTION)Jennifer Graves, Amy Waldman, Ben Greenberg, Gena Heidary, Amy Lavery, Darrel Conger, Leslie BensonNANOS 2018: Poster Presentations
64 The Use of Optical Coherence Tomography in Clinical and Subclinical Optic NeuritisJoao Lemos; Sara Matos; Andre Jorge; Ines Pais; Ana Martins; Ines Correia; Carla Nunes; Carmo Macario; Sonia Batista; Isabel Santana; Livia SousaNANOS Annual Meeting 2023: Poster Session II: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases
65 MS Treatment/Immune System TargetsRobert Shin, MDNANOS Annual Meeting 2023: Neuroimmunology: https://novel.utah.edu/collection/NAM/toc/
66 Longitudinal Inter-Eye Difference Threshold by Optical Coherence Tomography in Multiple Sclerosis (MS)Nathaniel Pasmanter, Nathan Lambert-Cheatham, Lina NagiaNANOS Annual Meeting 2022: Poster Session I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases
67 Good Therapies Gone Bad - What the Neuro-Ophthalmologist Needs to KnowFiona Costello, MD, FRCPNANOS Annual Meeting 2023: Neuroimmunology
68 Assessment of Retinal Sensitivity and Structural Integrity in Optic NeuritisRagib Khan; Swati Phuljhele; Rohit Saxena; Amar Pujari; Rebika Dhiman; Sanjay MishraNANOS Annual Meeting 2023: Poster Session II: Neuro-Ophthalmic Practice
69 Decreased Vision in Multiple Sclerosis is Associated With Novel Foveal Features Visualized Using Adaptive OpticsAubrey C. Hargrave, Lakshmi Leishangthem, May Han, Lucas Kipp, Fareshta Khushzad, Jennifer Yarp, Nripun Sredar, Alfredo Dubra, Heather MossNANOS Annual Meeting 2021: Scientific Platform Session I
70 Optical Coherence Tomography Macular Volume Correlates With Walking Speed in Patients with Multiple Sclerosis (.pdf)Meagan D. Seay, Fan Youran, Robert A. BermelNANOS Annual Meeting 2016: Poster Presentations
71 Should We Ever Consider Stopping Disease-Modifying Treatment for MS?Shin, RobertNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
72 Starting and Switching Multiple Sclerosis TherapySteven L. Galetta, MD, NYU LangoneNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
73 Associations Between Pattern Electroretinogram and Intra-retinal Layer Thicknesses in Patients Multiple SclerosisHong Jiang, Giovana Gameiro, Huiling Hu, Vittorio Porciatti, Pedro Monsalve, Jeffrey Hernandez, Siliva Delgado, Jianhua WangNANOS 2018: Scientific Platform I
74 External Validation of Predictive Models of Long-Term Visual Acuity in Acute Demyelinating Optic NeuritisAdrienne Jarocki, Etienne Benard-Seguin, Lizbeth Gonzales, Chris Andrews, Fiona Costello, Lindsey De LottNANOS Annual Meeting 2022: Poster Session I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases
75 LHON-MS patient with long-term non-response to Idebenone shows improvement after 4-AP UsageWilliam Sultan, Rustum Karanjia, Alfredo SadunNAM 2019: Poster Session I: Clinical Highlights in Neuro-Ophthalmology
51 - 75 of 1,153